Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2260studies shown
Showing 1-12 of 2,260
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

In Toronto
SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Other study type icon
RecruitingNCT05703685

PET brain imaging study for depression

This study is recruiting in the United States. It uses PET imaging to look at PDE4B in people with depression.

In Bethesda
DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Drug study icon
RecruitingNCT05895747

5-HTP and Creatine for Depression R33 Phase

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Salt Lake City
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
Depression
Drug study icon
RecruitingNCT06412315

7T Amygdala and Citalopram Study

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

In Oxford
DepressionDrugFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Other study type icon
RecruitingNCT07493551

A Bioequivalence Study of PP3M in people with Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.

In Beijing
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Condition
Schizophrenia
Other study type icon
RecruitingNCT07329621

Binding of MSP-2020 to Serotonin 5-HT2A Receptors for Depression

This study is recruiting in the United Kingdom. It is testing Binding of MSP-2020 to Serotonin 5-HT2A Receptors for Depression.

In London
DepressionOtherFrom 23 Years to 55 Years
Countries
United Kingdom
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Recruiting | Clinical Trials | HopeStage Research